Regeneron Files BLA For VEGF Trap-Eye In Wet AMD; Second Filing Anticipated This Year
If the ophthalmic product wins priority review, Roche could see competition for Lucentis in wet AMD by the fall.
If the ophthalmic product wins priority review, Roche could see competition for Lucentis in wet AMD by the fall.